These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32756297)

  • 1. Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against
    Amemiya K; Dankmeyer JL; Keasey SL; Trevino SR; Wormald MM; Halasohoris SA; Ribot WJ; Fetterer DP; Cote CK; Worsham PL; Adamovicz JJ; Ulrich RG
    Antibodies (Basel); 2020 Aug; 9(3):. PubMed ID: 32756297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model.
    Xiao X; Zhu Z; Dankmeyer JL; Wormald MM; Fast RL; Worsham PL; Cote CK; Amemiya K; Dimitrov DS
    PLoS One; 2010 Oct; 5(10):e13047. PubMed ID: 20976274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
    Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
    Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis.
    Anderson GW; Worsham PL; Bolt CR; Andrews GP; Welkos SL; Friedlander AM; Burans JP
    Am J Trop Med Hyg; 1997 Apr; 56(4):471-3. PubMed ID: 9158060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of mice with YscF provides protection from Yersinia pestis infections.
    Matson JS; Durick KA; Bradley DS; Nilles ML
    BMC Microbiol; 2005 Jun; 5():38. PubMed ID: 15978133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential human immunotherapeutics for plague.
    Andrianaivoarimanana V; Randriantseheno LN; Moore KM; Walker NJ; Lonsdale SG; Kempster S; Almond NA; Rajerison M; Williamson ED
    Immunother Adv; 2021 Jan; 1(1):ltab020. PubMed ID: 35919741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague.
    Garmory HS; Griffin KF; Brown KA; Titball RW
    Vaccine; 2003 Jun; 21(21-22):3051-7. PubMed ID: 12798649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples.
    Hsu HL; Chuang CC; Liang CC; Chiao DJ; Wu HL; Wu YP; Lin FP; Shyu RH
    BMC Infect Dis; 2018 Aug; 18(1):402. PubMed ID: 30107826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development, characterisation and diagnostic application of monoclonal antibodies against Yersinia pestis fibrinolysin and coagulase.
    Feodorova VA; Devdariani ZL
    J Med Microbiol; 2000 Mar; 49(3):261-269. PubMed ID: 10707946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis.
    Weeks S; Hill J; Friedlander A; Welkos S
    Microb Pathog; 2002 May; 32(5):227-37. PubMed ID: 12071679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.
    Goodin JL; Nellis DF; Powell BS; Vyas VV; Enama JT; Wang LC; Clark PK; Giardina SL; Adamovicz JJ; Michiel DF
    Protein Expr Purif; 2007 May; 53(1):63-79. PubMed ID: 17293124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
    Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague.
    Swietnicki W; Powell BS; Goodin J
    Protein Expr Purif; 2005 Jul; 42(1):166-72. PubMed ID: 15939303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of in vitro correlate assays of immunity to infection with Yersinia pestis.
    Bashaw J; Norris S; Weeks S; Trevino S; Adamovicz JJ; Welkos S
    Clin Vaccine Immunol; 2007 May; 14(5):605-16. PubMed ID: 17376861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
    Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J
    Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen.
    Chiuchiolo MJ; Boyer JL; Krause A; Senina S; Hackett NR; Crystal RG
    J Infect Dis; 2006 Nov; 194(9):1249-57. PubMed ID: 17041851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.